Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective ; volume:24 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
BMC public health ; 24, Heft 1 (21.8.2024), 1-10, 12.2024
- Urheber
-
Meng, Wenxin
Yang, Shudi
Wang, Zhangke
Xie, Jinping
Jiang, Rong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-19786-y
- URN
-
urn:nbn:de:101:1-2411072106386.312022427854
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meng, Wenxin
- Yang, Shudi
- Wang, Zhangke
- Xie, Jinping
- Jiang, Rong
- SpringerLink (Online service)
Ähnliche Objekte (12)
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Imaging manifestations of unusual side effects of new anticancer medications
MISSION FIELD REIMBURSEMENT FILE
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: Evidence from an online experiment
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Optimizing Patient Education of Oncology Medications: A Patient Perspective
The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
MEDICAL BILLS CLAIM FOR REIMBURSEMENT
Deposit Insurance: Reimbursement of Depositors
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda